• X
  • Login
  • Logout
  • Register
  • Account
SHTF Plan
  • #1 Crypto Stock!
  • Crisis Reports
  • Expert Manuals
  • Central Banks Digital Currency
  • Massive Recession
Select Page
Booster Shots For Everyone! FDA Authorizes a Third Shot For All Adults

Booster Shots For Everyone! FDA Authorizes a Third Shot For All Adults

by Mac Slavo | Nov 20, 2021 | Headline News

The Food and Drug Administration has authorized booster shots for everyone! All adults who have already gotten two shots should line up, obey the master’s commands, and get the third dose. Anyone who thinks it stops here at three shots is delusional. Previously...
There Are Magically Enough COVID Shots For Everyone, But Not Enough Other Drugs

There Are Magically Enough COVID Shots For Everyone, But Not Enough Other Drugs

by Mac Slavo | Nov 7, 2021 | Headline News

The supply chain shortages are seeming to affect every single sector of the economy, except the COVID-19 “vaccines.” Does anyone else find that strange at all? Especially now, considering supply chain disturbances are affecting prescription drugs now....
Kraft Heinz CEO Tells The Public To Get Used To Higher Food Prices

Kraft Heinz CEO Tells The Public To Get Used To Higher Food Prices

by Mac Slavo | Oct 14, 2021 | Headline News

According to Kraft Heinz CEO Miguel Patricio, the company is going to be “raising prices, where necessary, around the world.” Patricio says the general public should get used to higher prices for food. His comments follow a spike in government-induced energy and raw...
Merck Asks FDA For Emergency Approval Of New COVID Drug Despite Safety Concerns

Merck Asks FDA For Emergency Approval Of New COVID Drug Despite Safety Concerns

by Contributing Author | Oct 11, 2021 | Headline News

This article was originally published by Tyler Durden at ZeroHedge.  Despite warnings from scientists that its new COVID drug could have seriously harmful side effects like causing cancers and birth defects, Merck officially submitted the drug, Molnupiravir, to the...
Merck Charging US 40 Times What It Costs To Make Govt-Financed COVID Pill

Merck Charging US 40 Times What It Costs To Make Govt-Financed COVID Pill

by Contributing Author | Oct 7, 2021 | Headline News

This article was originally published by Tyler Durden at ZeroHedge.  Merck’s new ‘not Ivermectin’ Covid-19 treatment, molnupiravir, costs $17.74 to produce – yet the company is charging the US government $712 for the treatment – a 40x...
« Older Entries
Next Entries »

[the_ad_group id="30343"]

[the_ad_group id="30344"]

The content on this site is provided as general information only. The ideas expressed on this site are solely the opinions of the author(s) and do not necessarily represent the opinions of sponsors or firms affiliated with the author(s). The author may or may not have a financial interest in any company or advertiser referenced. Any action taken as a result of information, analysis, or advertisement on this site is ultimately the responsibility of the reader.

SHTFplan is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.

  • Home
  • Submit News & Articles
  • Contact Us
  • RSS Feed